

Fundamental dimension Equity attribute | LYVPeer $172.86▼-0.94% Cap $40.27BP/E -157.1x QuantScore45/100 | CEVMFLeader $58.550.00% Cap $5.62BP/E 19.7x QuantScore56/100 | FWONAPeer $82.59▼-1.38% Cap $20.70BP/E 44.9x QuantScore54/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
82/100 |
43/100 |
35/100 |
Valuation Multiples, PEG & DCF upside | 35/100 | 64/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 8/100 | 49/100 | 32/100 |
Growth Revenue / earnings growth & margins | 34/100 | 26/100 | 55/100 |
Sentiment Analyst ratings, targets & revisions | 69/100 | 100/100 | 75/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -157.1x | 19.7x | 44.9x |
Forward P/E (next FY) | -464.0x | 17.3x | 45.5x |
EV / EBITDA (TTM) | 25.1x | 8.5x | 17.3x |
Price / Sales | 1.5x | 1.8x | 4.8x |
Price / Free Cash Flow | 29.3x | 82.6x | 26.3x |
PEG ratio | 6.41 | 2.23 | 0.58 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 7 / 9 | 4 / 9 |
Altman Z-Score | 1.81 (Grey) | 2.45 (Grey) | 2.87 (Grey) |
Total debt / equity | 137.04 | 0.27 | 0.65 |
Quick ratio | 0.9x | 0.9x | 1.3x |
Interest coverage | 2.6x | 10.9x | 2.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +8.8% | +9.6% | +22.7% |
Net income growth YoY | -44.7% | -13.1% | +1950.0% |
Gross margin (TTM) | 44.8% | 25.9% | 32.8% |
Operating margin (FY) | 5.9% | 15.2% | 13.5% |
FCF margin (FY) | 1.2% | 4.3% | 16.8% |
5. Trailing price performancePrice change over period |
1M return | +1.4% | -13.8% | -5.2% |
3M return | -2.1% | -12.4% | -7.7% |
6M return | +10.7% | -4.0% | +1.0% |
Year to date | +21.7% | -37.8% | -8.0% |
1Y return | +13.5% | -36.3% | -6.0% |
3Y return | +120.7% | -2.8% | +36.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $184.27 +6.6% upside | $245.62 +319.5% upside | $302.65 +266.4% upside |
Wall Street consensus target | $208.27 +20.5% · range $183.00–$222.00 | — — | $119.50 +44.7% · range $115.00–$124.00 |
Consensus stance | 87% Buy13% Hold-0% Sell | 100% Buy0% Hold0% Sell | 75% Buy20% Hold5% Sell |